False
October 23, 2026
Industry leaders debate the manufacturing, regulatory, financial, and commercial barriers preventing advanced therapies from reaching more patients
1 min read
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.
The voices driving change and progress in medicine making. Explore stories, interviews, and community highlights that inspire and inform.
Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania Perelman School of Medicine
View Profile
Claudia Zylberberg discusses building the infrastructure, partnerships, and policies needed to bring advanced therapies to patients at scale
All the latest Medicine Maker articles.
October 21, 2026
Bristol Myers Squibb’s Robert Wethman discusses real-time spectroscopy, AI, and the next era of biopharmaceutical manufacturing
6 min read
October 21, 2026
The double-strand break-free approach increased functional GATA2 alleles and improved the engraftment of edited blood stem cells in mice
2 min read
October 20, 2026
Regeneron Genetics Center’s Luca Lotta explains how population-scale genetic evidence can reveal more promising drug targets and open new possibilities for disease prevention
4 min read
October 20, 2026
Piers Ingram discusses the resurgence of immunology, engineering-led drug discovery, and how artificial intelligence can shape the next generation of medicines
4 min read
October 20, 2026
Researchers develop AAV-based method to target cerebrospinal fluid production, revealing new insights into postnatal neurogenesis
2 min read
October 20, 2026
John Wichelt discusses Kindeva’s Bridgeton facility, supporting injectable programs from clinical development through commercial manufacturing, and choosing a long-term fill-finish partner
5 min read
October 19, 2026
Thoughtful label design and digital tools can help participants with dyslexia find and access essential clinical trial information
5 min read
October 19, 2026
An RNA sequencing and machine learning screening platform identified an RNA-processing factor that reduced markers of cellular aging without erasing cell identity
2 min read
October 19, 2026
First-in-human study demonstrates the potential of rapidly manufactured trispecific CAR T cells to deliver durable remissions in B-cell lymphoma
3 min read
October 19, 2026
Biotech boards are looking beyond big names to find leaders with the experience and flexibility to handle the company’s next major challenge.
6 min read
Receive the latest Medicine Maker news, personalities, education, and career development – weekly to your inbox.
False
